KRT88P and Hepatitis: The prospective screening of those individuals without previous data and still alive at the time of the study revealed an overall prevalence of hepatitis markers of 3.5% for anti-HCV, 1.3% for HBsAg, and 15.2% for isolated anti-HBc (Figure 2B).